Navigation Links
Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
Date:8/26/2008

The Drug Information Association (DIA), in collaboration with FDA, the Medical Imaging Contrast Agent Association (MICAA), the Council on Radionuclides and Radiopharmaceuticals (CORAR), PhRMA, and the American Medical Informatics Association (AMIA), will host Medical Imaging Continuum: Path Forward for Advancing the Uses of Medical Imaging in the Development of New Biopharmaceutical Products (October 2-3; Bethesda, MD)

Horsham, PA (Vocus) August 26, 2008-- http://www.diahome.org/ [The Drug Information Association (DIA)], in collaboration with FDA, the Medical Imaging Contrast Agent Association (MICAA), the Council on Radionuclides and Radiopharmaceuticals (CORAR), PhRMA, and the American Medical Informatics Association (AMIA), will host http://www.diahome.org/ [Medical Imaging Continuum: Path Forward for Advancing the Uses of Medical Imaging in the Development of New Biopharmaceutical Products] (October 2-3; Bethesda, MD)

This workshop will provide updates on the harmonization and standardization of the key elements required to meet the FDA review process and Proposed Draft Regulatory Guidance of 2011. This effort is currently in progress with PhRMA, the Extended PhRMA Imaging Group, CORAR, MICAA and many other stakeholders who are shaping best practices for standardizing medical imaging in clinical trials, including academia, professional imaging societies, non-profit consortia, governmental agencies, and regulatory authorities.

Attendees will discuss "Metrics for Quantifying the Quality of Imaging Enterprises in Clinical Trials" and "How to Standardize Image Acquisition, Transfer, and Analysis." Potential outcomes will include:

  • Endorsement of a rigorously defined metrics that quantify the quality of imaging enterprises in biopharmaceutical development;

  • An explanation of the issues surrounding the quantification of adjudication rates across therapeutic areas and imaging technologies;

  • Harmonization of imaging as a quantitative measure of drug-induced changes in multi-center clinical trials; and

  • The adoption of a standard, open-source, internet-based application for transferring data from sites of acquisition to central repositories.
"Working alongside experts from academia, professional imaging societies, non-profit consortia, and governmental agencies, meeting attendees will help to shape best practices for standardized medical imaging in clinical trials," notes Program Chair P. David Mozley, MD, Senior Director, Imaging, Merck Research Laboratories.

About the http://www.diahome.org/ [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Joe Krasowski
215-293-5812
Joe.Krasowski@diahome.org

###


Read the full story at http://www.prweb.com/releases/2008/08/prweb1237524.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. VOICES Launches Vote Kids 2008 to Engage Voters and Candidates in Shaping National Policies for Americas Children
2. Reshaping pharmaceutical quality
3. The Bank of New York Mellon Recognized as Change Agent Shaping the Direction of Healthcare Transaction Processing
4. Honda Criticized for Discriminatory Insurance Practices
5. URAC Reveals Distinguished Judges Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards
6. New Research From Best Practices: Pharmaceutical New Product Planning - Structure and Activities to Drive Growth and Profitability
7. Non-parental care of infants tied to unfavorable feeding practices
8. Associated Builders & Contractors, Inc. Launches Campaign Against Discriminatory Practices of Almac and Skanska USA
9. Best Practices: Achieving Excellence in Staffing and Recruiting Methods
10. High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance
11. Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Western University ... health services to the developmentally disabled in the Coachella Valley. , The two ... new facility at 71-949 Highway 111, Suite 100-B, in Rancho Mirage, California. The ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing ... February 2016. Each webinar features a dynamic expert and thoughtful presentation to give ... patients and facilities. Both events are free to attend, but registration is ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water ... were three leading bottled water brand owners that topped the list as a result ... and optimize conversion. The premier brand was Tibet 5100, a top notch water company ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, LLC, ... new approaches to the treatment of lupus and ... a multiple ascending dose study in patients with ... RSLV-132. --> --> ... multiple ascending dose study of RSLV-132 in 32 ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: